As a result of warrants being exercised, the number of shares and votes in XVIVO Perfusion AB (publ) has during June 2018 increased by 212,000 shares and votes. As of June 29, 2018 there are thus in total 26 402 496 shares and votes in the company.
June 29, 2018
Gothenburg
Christoffer Rosenblad, CFO
XVIVO Perfusion AB (publ)
For further information please contact:
Christoffer Rosenblad, CFO, +1 720 616 2101, christoffer.rosenblad@xvivoperfusion.com
Magnus Nilsson, CEO, +46 31 788 2150, magnus.nilsson@xvivoperfusion.com
For further information on XVIVO Perfusion’s business, please refer to the company’s website, www.xvivoperfusion.com
This information is information that Xvivo Perfusion AB (publ) is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact person set out above, at 8.30 am CET on June 29, 2018.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.